Medical Centre Sveti Dimitar – Vidin OOD
- Address
- 29, Khan Asparuh Blvd. fl. 2, 3700 Vidin, Bulgaria
Medical Centre Sveti Dimitar – Vidin OOD: COPD Research Center
Medical Centre Sveti Dimitar – Vidin OOD is a specialized research facility focused on respiratory medicine, with particular expertise in chronic obstructive pulmonary disease (COPD) and chronic bronchitis. The center participates in advanced clinical trials evaluating novel therapeutic approaches and combination therapies designed to improve outcomes for patients with chronic respiratory conditions.
- Evaluation of add-on therapies to maintenance triple therapy regimens for COPD exacerbation reduction
- Comparative efficacy studies of fixed-dose triple and dual combination therapies
- Assessment of novel pharmaceutical agents including CHF6001 DPI and CHF5993 formulations
The center's research portfolio emphasizes long-term efficacy studies with 52-week treatment durations, focusing on critical endpoints such as exacerbation rates and lung function parameters including pre-dose morning FEV1 measurements. Through participation in multicenter trials like TRITON, Medical Centre Sveti Dimitar contributes to advancing the understanding of optimal maintenance therapy combinations involving ICS, LABA, and LAMA components for patients with moderate to severe COPD.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Chiesi Farmaceutici S.p.A.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Centre Sveti Dimitar – Vidin OOD
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Tanimilast (CHF6001) as an Add-On to Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis | Chiesi Farmaceutici S.p.A. | Phase III | Not Recruiting | Jun 2021 | Jun 2025 |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tanimilast | 2 | Unknown | 2021-06-16 | 2021-06-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.